课题基金 / 基金详情

Improving Depression Screening in Rheumatology Clinics: Detection of Persistent Versus Acute Depression in Scleroderma Patients

Improving Depression Screening in Rheumatology Clinics: Detection of Persistent Versus Acute Depression in Scleroderma Patients
改善风湿病诊所的抑郁症筛查：硬皮病患者持续性抑郁症与急性抑郁症的检测
批准号：
201334
负责人：
Milette Katherine
金额：
$1.27万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-02-01 至 2011-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=201334&lang=en
关键词：
Depression Screening Scleroderma

项目摘要

项目成果

Milette Katherine的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background & Hypothesis: Scleroderma (SSc) is a chronic autoimmune, multisystem disorder of connective tissue characterized by thickening of the skin and by problems involving internal organs. A recent study found that 36-65% of patients with SSc met crit
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Barriers to depression screening in medical settings: Examining cumulative false-positive rates and possible solutions in rheumatology, oncology, and cardiovascular care settings.
Improving Depression Screening in Rheumatology Clinics: Detection of Persistent Versus Acute Depression in Scleroderma Patients
海外基金